DISCLAIMER: This site is for informational purposes only. While we make every effort to keep it up to date, there is no guarantee that information is complete, accurate, comprehensive, or the same for all KP regions. The information on this site should not be interpreted or used as a substitute for professional medical care. Please consult your care provider for any personal health questions or before participating in clinical trials.

Search Results

Tip

Your search for Obstetrics and Gynecology | All Regions returned 36 studies.

Active, currently enrolling Who can join

OptimICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy With Checkpoint Inhibitor Therapy

Keywords: Oncology (Adult);Obstetrics and Gynecology;
Study Type: INTERVENTIONAL | Region: California - Northern

Active, currently enrolling Who can join

Case-Control Study II of Genomic Markers in Menstrual Blood for Diagnosis of Uterine Disorders

Keywords: Obstetrics and Gynecology;Endometriosis; Uterine Disorders
Study Type: OBSERVATIONAL | Region: Colorado

Enrollment complete Who can join

A Phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based chemotherapy in women with recurrent platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer

Keywords: Oncology (Adult);Obstetrics and Gynecology;
Study Type: INTERVENTIONAL | Region: California - Northern

Enrollment on hold Who can join

A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer

Keywords: Oncology (Adult);Obstetrics and Gynecology;
Study Type: INTERVENTIONAL | Region: California - Northern

Enrollment complete Who can join

Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer (e3)

Keywords: Oncology (Adult);Obstetrics and Gynecology;
Study Type: INTERVENTIONAL | Region: California - Northern

Enrollment complete Who can join

A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With = 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy

Keywords: Oncology (Adult);Obstetrics and Gynecology;
Study Type: INTERVENTIONAL | Region: California - Northern

Enrollment on hold Who can join

A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming With Intradermal BCG Before Intravesical Therapy for BCG-Naive High-Grade Non-muscle Invasive Bladder Cancer

Keywords: Oncology (Adult);Obstetrics and Gynecology;Urology;
Study Type: INTERVENTIONAL | Region: California - Northern

Enrollment complete Who can join

Tomosynthesis Mammographic Imaging Screening Trial (TMIST)

Keywords: Oncology (Adult);Obstetrics and Gynecology;
Study Type: INTERVENTIONAL | Region: California - Northern

Enrollment on hold Who can join

RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation With Breast Reconstruction

Keywords: Obstetrics and Gynecology;Oncology (Adult);
Study Type: INTERVENTIONAL | Region: California - Northern

Enrollment complete Who can join

Alternate Approaches for Clinical Stage II or III Estrogen Receptor Positive Breast Cancer Neoadjuvant Treatment (ALTERNATE) in Postmenopausal Women: A Phase III Study

Keywords: Oncology (Adult);Obstetrics and Gynecology;
Study Type: INTERVENTIONAL | Region: California - Northern

1